Telangana Govt restocks Covid-19 vaccine, but beneficiaries a no-show

Amid Covid warnings, rush for vax increases

For India, heterologous booster shots are the next step in mitigating the spread of COVID-19 and its mutations

This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed

It would result in end users paying a price of Rs 400 a dose, including taxes and administration charges

Authorisation given to Cadila for its ZyCoV-D for an additional dose of 3mg with a two-jab inoculation schedule for those aged above 12

SEC has recommended restricted emergency use of Biological E\'s COVID-19 vaccine, Corbevax, in children aged 5-12 years

Health personnel in the state have administered CorBevax to nearly 45,000 children in the last two days

As of March 1, 2021, there were 4.7 crore children aged 12 and 13 years in the country

About 17.23 lakh minors in the 12-14 years age group are estimated to be eligible for Corbevax vaccine

The co-morbidity clause for administering precaution doses to senior citizens to be removed

The Drugs Controller General of India (DCGI) is expected to give final EUA to Corbevax soo

Corbevax is administered through the intramuscular route with two doses scheduled 28 days apart

The government has not taken a decision yet on vaccinating those aged below 15 years

The move makes Corbevax the second covid vaccine to be approved for administration to children in India

The remarks came after DCGI recommended Emergency Use Authorization to Biological E\'s vaccine, Corbevax

Union health minister Mansukh Mandaviya said the decision to start vaccination for minors would be taken based on expertsâ€™ recommendations

DCGI has already approved Corbevax for restricted use in emergency situation among adults on December 28

With this approval, the number of Covid-19 vaccines which have received emergency use authorisation in the country has risen to eight